Bhuvan Chugh: Endocrine Therapy in Invasive Lobular Breast Cancer
Bhuvan Chugh, Lead Consultant at Apollo Hospitals, shared on LinkedIn: “Invasive lobular breast cancer is not just ductal cancer with a different shape. Its biology is different. ER-Axis is…
Read the full articleYou might also wanna read
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
Conditions : Advanced Breast Cancer; Metastatic Breast Cancer; HER2 Positive; HR Positive Interventions : Drug: Trastuzumab deruxtecan; Drug
Germline Variants Predict Lobular Breast Cancer Recurrence
For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence. Medscape M
Lobular breast cancer
Lobular breast cancer begins in the glands that make milk during breastfeeding. Charities and patient groups have called for more research o
Breast Cancer Treatment Strategies: AI ± CDK4/6 Inhibitors, Biomarkers, and ESR1 Mutations
Did you know that the prevalence of acquired ESR1 mutations increases after exposure to endocrine therapy?
mdsc.pe·23d ago
Study compares surgeries for reducing ovarian cancer risk in women at high risk for the disease
Interview with Rinki Agarwal, MD, an associate professor of obstetrics and gynecology at Upstate
How breast cancer is diagnosed and treated
Interview with Ranjna Sharma, MD, chief of breast surgery and medical director of the breast cancer program at Upstate
Comments
Sign in to join the conversation.
No comments yet. Be the first.